ANDA 80271, held by Usl Pharma. Methyltestosterone.
As of Nov 14, 2026, ANDA 80271 (Methyltestosterone), held by Usl Pharma, was first approved by FDA on Jun 28, 1993, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methyltestosterone10MG ยท tablet;buccal, sublingual | Methyltestosterone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
